Impact of Remote Monitoring on Long-Term Prognosis in Heart Failure Patients in a Real-World Cohort: Results From All-Comers COMMIT-HF Trial.

Remote Monitoring in Real-World Cohort Background Randomized controlled trials demonstrate that remote monitoring (RM) of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-Ds) may improve quality of care and prognosis in heart failure (HF) patients. Ho...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Cardiovascular Electrophysiology Vol. 28; no. 4; pp. 425 - 432
Autores principales: KUREK, ANNA, TAJSTRA, MATEUSZ, GADULA‐GACEK, ELZBIETA, BUCHTA, PIOTR, SKRZYPEK, MICHAL, PYKA, LUKASZ, WASIAK, MICHAL, SWIETLINSKA, MALGORZATA, HAWRANEK, MICHAL, POLONSKI, LECH, GASIOR, MARIUSZ, KOSIUK, JEDRZEJ
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Apr2017
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=122602803&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 122602803
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10453873
        GSB
      jtl: Journal of Cardiovascular Electrophysiology
      issn: 10453873
      maglogo: Y
    pubinfo:
      dt: Apr2017
      vid: 28
      iid: 4
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        122602803
        122602803
        122602803
        10.1111/jce.13174
        122602803
      ppf: 425
      ppct: 7
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Impact of Remote Monitoring on Long-Term Prognosis in Heart Failure Patients in a Real-World Cohort: Results From All-Comers COMMIT-HF Trial.
      aug:
        au:
          KUREK, ANNA
          TAJSTRA, MATEUSZ
          GADULA‐GACEK, ELZBIETA
          BUCHTA, PIOTR
          SKRZYPEK, MICHAL
          PYKA, LUKASZ
          WASIAK, MICHAL
          SWIETLINSKA, MALGORZATA
          HAWRANEK, MICHAL
          POLONSKI, LECH
          GASIOR, MARIUSZ
          KOSIUK, JEDRZEJ
        affil: 3rd Department of Cardiology, Silesian Centre for Heart Diseases, Medical University of Silesia, Zabrze Poland
      sug:
        subj:
          Remote Access to Information
          Outcomes (Health Care)
          Monitoring, Physiologic
          Heart Failure Diagnosis
          Human
          Defibrillators, Implantable
          Equipment and Supplies
          Cardiac Resynchronization Therapy
          Cardiac Patients
          Prospective Studies
          Patient Assessment
          Patient History Taking
          Hospitalization
          Mortality
          Data Collection
          Control Group
          Middle Age
          Male
          Female
          Heart Diseases Classification
          Kidney Failure, Chronic
          Diabetes Mellitus
          Hypertension Diagnosis
          Hyperlipidemia
          Angiotensin-Converting Enzyme Inhibitors
          Angiotensin II Type I Receptor Blockers
          Statins
          Data Analysis Software
          Middle Aged: 45-64 years
          Male
          Female
      ab: Remote Monitoring in Real-World Cohort Background Randomized controlled trials demonstrate that remote monitoring (RM) of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-Ds) may improve quality of care and prognosis in heart failure (HF) patients. However, the impact of RM on long-term mortality in a real-world cohort is still not well examined. Methods and Results This study was designed as a matched cohort study based on the COMMIT-HF trial--a single-center, ongoing prospective observational registry (NCT02536443). Complete patient demographics, medical history, in-hospital results, hospitalizations, and mortality data were collected based on institutional registries and healthcare providers' records. Patients were divided into 2 groups based on RM presence and matched by means of propensity scores according to clinical characteristics. The primary endpoint of this study was the long-term all-cause mortality. Out of 1,429 consecutive patients, 822 patients with a first implantation of an ICD/CRT-D were included in the analysis. The final matched study population contained 574 patients in RM and in a control group. Although demographic and echocardiographic parameters as well as pharmacological treatments were similar in both groups, a significantly lower 1-year mortality was detected in the RM group (2.1% vs. 11.5%, P < 0.0001). This was also maintained during a 3-year follow-up (4.9% vs. 22.3%, P < 0.0001). Multivariate analysis showed that RM was associated with an improved prognosis (hazard ratio 0.187, 95% confidence interval 0.075-0.467, P = 0.0003). Conclusion RM of HF patients with ICDs/CRT-Ds significantly reduced long-term mortality in a real-world clinical condition.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N